Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs.
The sensitivity to the fibrosis-inducing effect of bleomycin varies considerably from species to species, the reasons for which are unknown. The variability of the response in different strains of mice is well documented. Recent evidence indicates that the upregulated expression of cytokines and cytokine receptors may be involved. We evaluated the expression pattern of some cytokines and their receptors in C57Bl/6J bleomycin-sensitive and Balb/C bleomycin-resistant mice. Animals from both strains received, under ether anesthesia, either saline (50 microl) or bleomycin (0.1 U/50 microl) intratracheally. At various times after the treatment, the lungs were analyzed for cytokines and cytokine receptors by histochemistry and their mRNA by RNase protection assay. A significantly increased expression of TNF-alpha and IL-1beta was observed in both strains. However, an upregulated lung expression for TNF-alpha and IL-1 receptors was observed in C57Bl/6J-sensitive animals only. This profile is evident from 63 h onward. In addition to TNF-alpha, bleomycin administration also resulted in the upregulated expression of TGF-beta in the lungs of both strains at 8 h and in an enhanced expression of TGF-beta receptors I and II in C57Bl/6J mice only. The upregulation of TGF-beta receptor expression was preceded in this strain by an increased expression of IL-4, IL-13, and IL-13 receptor-alpha (at 8 h after bleomycin) and followed by an upregulation of gp130 and IL-6. The difference we observed in the cytokine receptor profile may offer an additional explanation for the different fibrogenic response of the two mouse strains to bleomycin.
Department of Physiopathology, Experimental Medicine & Public Health, University of Siena, Via Aldo Moro, Siena, Italy I-53100.
Eleonora
E
Cavarra
Fabio
F
Carraro
Silvia
S
Fineschi
Antonella
A
Naldini
Barbara
B
Bartalesi
Annalisa
A
Pucci
Giuseppe
G
Lungarella
D000818:Animals; D001761:Bleomycin / Q000633:toxicity*; D016207:Cytokines / Q000235:genetics*; D005786:Gene Expression Regulation / Q000187:drug effects*; D007150:Immunohistochemistry; D008168:Lung / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D012333:RNA, Messenger / Q000235:genetics; D018121:Receptors, Cytokine / Q000187:drug effects / Q000235:genetics*; D017472:Receptors, Interleukin-1 / Q000187:drug effects / Q000235:genetics
D016207:Cytokines; D012333:RNA, Messenger; D018121:Receptors, Cytokine; D017472:Receptors, Interleukin-1; D001761:Bleomycin